These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 38899058

  • 1. A case report of AQP4-IgG-seropositive refractory neuromyelitis optica spectrum disorder patient with Sjögren's syndrome and pancytopenia treated with inebilizumab.
    Li S, Gao Y, He Y, Zhang Z.
    Front Neurol; 2024; 15():1371515. PubMed ID: 38899058
    [Abstract] [Full Text] [Related]

  • 2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R, Roy D, León-Ruiz M, Das S, Dubey S, Benito-León J.
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [Abstract] [Full Text] [Related]

  • 3. AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
    Marignier R, Pittock SJ, Paul F, Kim HJ, Bennett JL, Weinshenker BG, Wingerchuk DM, Green AJ, Fujihara K, Cutter G, Aktas O, Hartung HP, Drappa J, Ratchford JN, She D, Smith M, Rees W, Cimbora D, Katz E, Cree BAC, N-MOmentum study investigators.
    Mult Scler Relat Disord; 2022 Jan; 57():103356. PubMed ID: 35158465
    [Abstract] [Full Text] [Related]

  • 4. Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder.
    Nie T, Blair HA.
    CNS Drugs; 2022 Oct; 36(10):1133-1141. PubMed ID: 36070074
    [Abstract] [Full Text] [Related]

  • 5. Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder.
    Clardy SL, Pittock SJ, Aktas O, Nakahara J, Isobe N, Centonze D, Fam S, Kielhorn A, Yu JC, Jansen J, Zhang I.
    Neurol Ther; 2024 Jun; 13(3):535-549. PubMed ID: 38722571
    [Abstract] [Full Text] [Related]

  • 6. Syringomyelia-like syndrome in neuromyelitis optica spectrum disorder complicated with Sjogren's syndrome: a case report.
    Li X, Lu Z, Wang Y.
    BMC Neurol; 2018 Oct 09; 18(1):168. PubMed ID: 30301458
    [Abstract] [Full Text] [Related]

  • 7. Advances in the long-term treatment of neuromyelitis optica spectrum disorder.
    Anderson M, Levy M.
    J Cent Nerv Syst Dis; 2024 Oct 09; 16():11795735241231094. PubMed ID: 38312734
    [Abstract] [Full Text] [Related]

  • 8. [Pregnancy-associated neuromyelitis optical spectrum disorder combined with primary Sjögren's syndrome: A critical illness case report].
    Wu J, Zhang W, Liang S, Qin YL, Fan WQ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec 18; 55(6):1118-1124. PubMed ID: 38101798
    [Abstract] [Full Text] [Related]

  • 9. Sjögren's syndrome and neuromyelitis optica spectrum disorders (NMOSD)--a case report and review of literature.
    Jayarangaiah A, Sehgal R, Epperla N.
    BMC Neurol; 2014 Oct 09; 14():200. PubMed ID: 25291981
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjögren's syndrome: a systematic review of individual patient data.
    Prasad CB, Kopp CR, Naidu G, Sharma V, Misra DP, Agarwal V, Sharma A.
    Rheumatol Int; 2023 Jul 27. PubMed ID: 37500817
    [Abstract] [Full Text] [Related]

  • 12. A Case of Primary Sjögren's Syndrome Presenting as Mass-Like Encephalitis, With Progression to Neuromyelitis Optica Spectrum Disorder.
    Lee HJ, Chang SH, Kang EH, Lee YJ, Song YW, Ha YJ.
    Arch Rheumatol; 2017 Dec 27; 32(4):353-357. PubMed ID: 29901009
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The First Case Report of Preschool-Onset SS/SLE Coexisting With NMOSD of Chinese Origin.
    Liu L, Tang L, Zhang L, Li X, Huang P, Xiong J, Xiao Y, Liu L.
    Front Immunol; 2022 Dec 27; 13():887041. PubMed ID: 35585974
    [Abstract] [Full Text] [Related]

  • 15. Time-Dependent Analysis of Sicca Symptoms and Anti-Ro/SSA and Anti-La/SSB Antibodies in Patients with AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
    Akaishi T, Takahashi T, Misu T, Fujihara K, Nakashima I, Aoki M.
    Tohoku J Exp Med; 2023 Jul 08; 260(3):215-221. PubMed ID: 37081618
    [Abstract] [Full Text] [Related]

  • 16. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
    Martín-Nares E, Hernandez-Molina G, Fragoso-Loyo H.
    Lupus; 2019 Oct 08; 28(11):1302-1311. PubMed ID: 31566079
    [Abstract] [Full Text] [Related]

  • 17. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
    Akaishi T, Takahashi T, Fujihara K, Misu T, Fujimori J, Takai Y, Nishiyama S, Abe M, Ishii T, Aoki M, Nakashima I.
    J Neurol; 2021 May 08; 268(5):1938-1944. PubMed ID: 33416998
    [Abstract] [Full Text] [Related]

  • 18. The prevalence and clinical phenotype of dual seropositive neuromyelitis optica spectrum disorders at a national reference center in South Asia.
    Lalwani CS, Faisal F, Yadav A, Kannoth S, Nambiar V, Gopinath S, Kumar A, Umesh SU, Vincent J, Anoop S, Mathai A, Panicker S.
    Mult Scler Relat Disord; 2023 Jul 08; 75():104736. PubMed ID: 37126965
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD.
    Redenbaugh V, Flanagan EP.
    Neurotherapeutics; 2022 Apr 08; 19(3):808-822. PubMed ID: 35267170
    [Abstract] [Full Text] [Related]

  • 20. Cortical blindness and not optic neuritis as a cause of vision loss in a Sjögren's syndrome (SS) patient with the neuromyelitis optica spectrum disorder (NMOSD): Challenges of ascribing demyelinating syndromes to SS: a case report.
    Lalji A, Izbudak I, Birnbaum J.
    Medicine (Baltimore); 2017 Aug 08; 96(34):e7454. PubMed ID: 28834867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.